Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

High dose intravenous methylprednisolone for Kassabach-Merritt syndrome

Abstract

Kassabach-Merritt syndrome involving the sternum in a 2-month-old child is described. Treatment with high dose intravenous methylprednisolone resulted in normalization of the platelet count and disappearence of haemangioma.

This is a preview of subscription content, log in to check access.

Abbreviations

K-MS:

Kassabach-Merritt syndrome

DIC:

disseminated intravascular coagulation

i.v. MP:

intravenous methylprednisolone

References

  1. 1.

    Bell AJ, Chisholm M, Hickton M (1986) Reversal of coagulopathy in Kassabach-Merritt syndrome with tranexamic acid. Scand J Haematol 37:249–252

  2. 2.

    Evans J, Batchelor ADR, Stark G, Uttley W (1975) Hemangioma with coagulopathy. Sustained response to prednisone. Arch Dis Child 50:909–912

  3. 3.

    Hurvits CH, Alkalay AL, Sloninsky L, Kallus M, Pomerance JJ (1986) Cyclophosphamide therapy in life threatining vascular tumors. J Pediatr 109:360–363

  4. 4.

    Inceman S, Tangün Y (1969) Chronic defibrination syndrome due to a giant hemangioma associated with microangiopathic hemolytic anemia. Am J Med 46:997–1002

  5. 5.

    Kassabach HH, Merritt KK (1940) Cavernous hemangioma with extensive pupura: report of a case. Am J Dis Child 59:1063–1070

  6. 6.

    Messaritakis J, Anagnostakis D, Feingold M (1986) Benign neonatal hemangiomatosis. Am J Dis Child 140:447–448

  7. 7.

    Özsoylu Ş (1987) High-dose intravenous corticosteroid for a patient with Diamond-Blackfan syndrome refractory to classical prednisone treatment. Acta Haematol 21:207–210

  8. 8.

    Özsoylu Ş (1987) High-dose intravenous methylprednisolone for refractory or resistant Diamond-Blackfan anemia. Eur J Haematol 39:190–191

  9. 9.

    Özsoylu Ş (1987) High dose intravenous methylprednisolone in treatment of recessive osteropetrosis. Arch Dis Child 62:214–215

  10. 10.

    Özsoylu Ş (1987) High dose intravenous methylprednisolone for the treatment of childhood chronic idiopathic thrombocytopenic purpura. Pediatr Rev Common 2:29–40

  11. 11.

    Özsoylu Ş, Ruacan Ş (1986) High d0se intravenous corticosteroid treatment in childhood idiopathic myelofibrosis. Acta Haematol 75:49–51

  12. 12.

    Özsoylu Ş, Strauss HS, Diamond LK (1962) Effect of corticosteroids on coagulation of the blood. Nature 195:1214–1215

  13. 13.

    Özsoylu Ş, Coşkun T, Minassezzi S (1984) High dose intravenous glucocorticoid in the treatment of childhood acquired aplastic anemia. Scand J Haematol 33:309–316

  14. 14.

    Özsoylu Ş, Ertürk G, Tokatli A (1986) Gammaglobulin and methylprednisolone in idiopathic thrombocytopenic purpura. Eur J Pediatr 145:157–158

  15. 15.

    Özsoylu Ş, Irken G, Karabent A (1988) High dose intravenous methylprednisolone for acute childhood idiopathic thrombocytopenic purpura. Eur J Haematol (accepted for publication)

  16. 16.

    Stanley P, Comperts E, Wooley MM (1986) Kassabach-Merritt syndrome treated by therapeutic embolization with polyvinyl alcohol. Am J Pediatr Hematol Oncol 8:308–311

  17. 17.

    Wacksman SJ, Flessa HC, Glueck HI, Will JJ (1966) Coagulation defects and giant cavernous hemangioma. A case study in infancy. Am J Dis Child 111:71–78

  18. 18.

    Warrell RP Jr Kempin SJ (1985) Treatment of severe coagulopathy in the Kassabach-Merritt syndrome with aminocaproic acid and cryoprecipitate. N Engl J Med 313:309–312

Download references

Author information

Correspondence to S. Özsoylu.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Özsoylu, S., Irken, G. & Gürgey, A. High dose intravenous methylprednisolone for Kassabach-Merritt syndrome. Eur J Pediatr 148, 403–405 (1989). https://doi.org/10.1007/BF00595897

Download citation

Key words

  • Kassabach-Merritt syndrome
  • High dose intravenous methylprednisolone treatment